Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2019 | Story Ruan Bruwer | Photo Varsity Cup
Lubabalo Dobela
Flyhalf Lubabalo Dobela will be an important cog in the wheel for the Shimlas against the Maties in the semi-final stage of the Varsity Cup. He has been named Player that Rocks twice this year.

The Shimlas (University of the Free State) will go into the semi-final against the unbeaten Maties with confidence, knowing that they can compete against them, said coach Hendro Scholtz.

The Shimlas will travel to Stellenbosch for the Varsity Cup clash on Monday (8 April). They qualified for the play-offs thanks to a 38-14 victory over the University of Johannesburg (UJ) in the final round of the competition on Monday 1 April 2019.

The Free State students lost to the Maties by 59-14 two weeks ago, and although the score reflects a big hiding, the Shimlas stood tall for most of the encounter.

“With 18 minutes remaining, we trailed by only ten points (14-24). We can gain confidence from that. We learned a couple of things about them. We will have to stop their driving mall and be sharp when it comes to our discipline. They will hurt us if we concede penalties,” said Scholtz.

According to him, it is important to get off to a good start. “You often sit with students who have other things to think about apart from rugby, such as upcoming tests, which can hamper their concentration. Against UJ in the wet, it was important to play the conditions right, and I think it made the players concentrate that little bit more.”

The Shimlas won four of their eight group matches and will look back on their defeats against the Pukke and Ixias as matches that they could easily have won on another day.

It is the fifth time in the 12 years of the Varsity Cup that the Shimlas have reached the final-four stage, with one win in 2015 over the Ikeys.

The Shimlas will be without two of their key men among the forwards – the injured flank Janco Cloete and hooker Hanno Snyman.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept